Nature's Sunshine (NATR) Q2 Earnings Report Preview: What To Look For

Nature’s Sunshine (NATR) will report Q2 earnings Thursday after the bell. The company previously reported Q1 revenue of $122.9M, up 8.5% YoY, and beat analysts on EPS and EBITDA. For Q2, analysts expect revenue up 7.8% YoY. The article cites an average analyst price target of $34.50 vs a $20.45 share price.

Original reporting
Published Aug 5, 2026, 3:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 5, 2026, 4:45 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Nature's Sunshine (NATR) Q2 Earnings Report Preview: What To Look For — source image
Decision brief

The 30-second read

$NATRNeutralMed
01

Why it matters

The main tradable element is the earnings timing plus consensus revenue growth and the stock’s relative underperformance versus the personal care segment, which can influence expectations and positioning into the print.

02

Market read

This preview frames what to watch in NATR’s upcoming earnings, using consensus growth, prior-quarter performance, and peer read-across.

03

What to watch

No guidance, margin drivers, or product/order details are provided, so traders may be underestimating the risk that the market focuses on profitability or forward commentary rather than revenue growth.

Relevance 4/10Novelty 4/10Timing: pre-market into Thursday after-the-bell earnings

Background

Nature’s Sunshine is previewed ahead of its Q2 earnings release after the bell on Thursday, following a prior-quarter revenue and EPS/EBITDA beat.

Company-level read

Ticker impact

$NATRNeutralMedium confidence
Context

Nature’s Sunshine is set to report Q2 earnings after the bell, with the article citing revenue growth expectations and recent estimate reconfirmations.

Expected impact

Near-term volatility is likely around the after-hours earnings print, with upside/downside driven by whether revenue growth and margins/EBITDA align with expectations.

Evidence & confidence

The article provides consensus growth (7.8% YoY) and notes prior-quarter beats, but it does not disclose any new company-specific development beyond the upcoming earnings timing and estimate context.

Market effects

Personal care peers’ mixed Q2 results (Medifast down YoY, USANA down YoY) may shape read-across expectations for NATR’s margin and demand signals.

None stated.

None stated.

Counterpoint

Because the article stresses that NATR “rarely misses” revenue estimates, the market may instead trade the earnings quality (EBITDA/margins) rather than the top-line beat.

Key entities

  • Nature’s Sunshine

    NASDAQ-listed wellness products company scheduled to report Q2 earnings after the bell Thursday.

  • Medifast

    Personal care peer referenced for its Q2 revenue decline and post-results stock reaction.

  • USANA

    Personal care peer referenced for its Q2 revenue decline and miss versus expectations.

Related articles

$NATRMedAI 8/10

Nature's Sunshine (NATR) Stock Trades Down, Here Is Why

Nature’s Sunshine (NASDAQ: NATR) shares fell 17.7% after the company reported Q2 2026 results that missed Wall Street. Revenue was $117 million, 5.4% below estimates, and adjusted EPS was $0.21, 22.2% below expectations. It also cut full-year revenue guidance to $495 million at the midpoint, down 2.5% from prior guidance.

$NATRMed

NATURES SUNSHINE PRODUCTS INC (NATR): Results of Operations and Financial Condition

NATURES SUNSHINE PRODUCTS INC (NATR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 3 natrq22026earningsrelease.htm EX-99.1 Document Nature's Sunshine Reports Second Quarter 2026 Results Net Sales up 2% to $117.0 million, Gross Profit Margin up 194 Basis Points to 73.7% LEHI, Utah – August 6, 2026 – Nature’s Sunshine Products, Inc. (Nasdaq: NATR) ("Natur

$DTMedAI 8/10

Dynatrace Springs on Q1 Figures

Dynatrace (NYSE: DT) reported Q1 FY2027 results for the quarter ended June 30, 2026. Total ARR was $2,136 million, up 17%. Total revenue rose to $555 million, up 16%. Subscription revenue was $530 million. GAAP operating income was $71 million and non-GAAP $162 million. CEO Rick McConnell cited 41% organic net new ARR growth and accelerating TTM growth.

$DBXMed

Dropbox Shares Decline Despite Earnings Beat as Revenue Growth Disappoints

Dropbox (DBX) shares fell about 5% premarket to around $32.80 after Q2 2026 results. The company reported adjusted EPS of $0.75 vs $0.74 expected and revenue of $631.5M vs about $627M, but revenue rose only 0.9% year over year. Non-GAAP operating margin improved to 39.7%. Paying users reached 18.19M. William Blair upgraded to Market Perform, while consensus remains Sell.

$HLMedAI 8/10

Hecla Mining Q2 Earnings Call Highlights

Hecla Mining reported Q2 financial and operating updates. The company ended the quarter with $483 million cash, about $472 million net cash, and an essentially undrawn $225 million revolver. It projected 2026 free cash flow of about $500 million at $50 silver and $3,500 gold, and raised Greens Creek silver guidance to 8.0-8.3 million ounces. Production guidance was adjusted for Lucky Friday and Keno Hill.